Related Experiment Video
Updated: Oct 1, 2026

Assessment of Respiratory Function in Conscious Mice by Double-chamber Plethysmography
Published on: July 10, 2018
Forced expiratory time and bronchial hyperresponsiveness to methacholine
Marc F Goldstein1, Bernadette A Veza, Arlene Lauf-Goldstein
1Department of Medicine and Pediatrics, MCP Hahnemann University School of Medicine, Philadelphia, Pennsylvania, USA. gpike@aol.com
Abstract:
Pulmonary junction tests (PFTs) are normally performed prior to methacholine inhalation challenges (MICs). In contrast to normal baseline spirometry (FEV1, FEF25%-27%, FVC), we have observed patients with positive MICs having shortened forced expiratory times (FET100%) in the baseline pre-MIC PFT. We prospectively evaluated the correlation of abnormalities in baseline pre-MIC FET100% in patients who have positive vs. negative MICs. Prospective analysis of baseline pre- MIC FET100%, and MIC results in suspected asthmatics with normal lung exams, spirometry and chest x-rays. Using a PC20 FEV1 of < or =8mg/ml methacholine there were 115 positive and 69 negative MICs. The mean (+/-1 SD) FET100% in the positive MIC group was 3.57+/-1.68 sec vs. 4.73+/-1.60 sec in the negative group. The difference in these means was statistically significant (p <0.0001). There was a statistically significant difference in the incidence of FET100% <4sec in the positive (55.65%) vs. the negative (30.43%) MIC group, p<0.001. There was also a statistically significant difference in the incidence of positive MIC in FET100% <4sec (75.29%) vs. FET100%, > or =4sec (51.52%), p< 0.001. Our results suggest that in our highly selected, well-characterized population, FET100.% <6sec is common and FET100% <4 sec correlates with an increased likelihood of having a positive MIC.
Related Concept Videos
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic Obstructive Pulmonary Disease II: Emphysema
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Asthma III: Clinical Manifestations
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
Chronic Obstructive Pulmonary Disease I: Introduction

